Zoetis (ZTS) Receivables (2012 - 2026)
Zoetis (ZTS) posted quarterly Receivables of $1.5 billion for Q1 2026, up 10.65% year-over-year from $1.4 billion in Q1 2025, and up 1.89% quarter-over-quarter from $1.5 billion in Q4 2025.
Zoetis (ZTS) Receivables (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Receivables for 15 consecutive years, with $1.5 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables rose 10.65% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (up 10.65% YoY), while the FY2025 annual figure was $1.7 billion, up 18.92% from the prior year.
- Receivables advanced to $1.5 billion in Q1 2026 per ZTS's latest filing, from $1.5 billion in the prior quarter.
- Across five years, Receivables topped out at $1.5 billion in Q3 2025 and bottomed at $1.2 billion in Q1 2023.
- Historically, Receivables has averaged $1.4 billion across 5 years, with a median of $1.4 billion in 2025.
- Annual changes were most pronounced in 2023 — Receivables retreated 2.95% — and 2024, when it climbed 12.25%.
- Zoetis' Receivables stood at $1.3 billion in 2022, then increased by 5.91% to $1.4 billion in 2023, then gained by 2.42% to $1.4 billion in 2024, then gained by 5.95% to $1.5 billion in 2025, then gained by 1.89% to $1.5 billion in 2026.
- Business Quant data shows ZTS's Receivables at $1.5 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.08 Bn |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | 456.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.57 Bn |
| Mar 31, 2026 | 1.51 Bn |
| Dec 31, 2025 | 1.48 Bn |
| Sep 30, 2025 | 1.54 Bn |
| Jun 30, 2025 | 1.54 Bn |
| Mar 31, 2025 | 1.36 Bn |
| Dec 31, 2024 | 1.40 Bn |
| Sep 30, 2024 | 1.41 Bn |
| Jun 30, 2024 | 1.38 Bn |
| Mar 31, 2024 | 1.29 Bn |
| Dec 31, 2023 | 1.36 Bn |
| Sep 30, 2023 | 1.26 Bn |
| Jun 30, 2023 | 1.32 Bn |
| Mar 31, 2023 | 1.19 Bn |
| Dec 31, 2022 | 1.29 Bn |
| Sep 30, 2022 | 1.19 Bn |
| Jun 30, 2022 | 1.29 Bn |
| Mar 31, 2022 | 1.22 Bn |
| Dec 31, 2021 | 1.18 Bn |
| Sep 30, 2021 | 1.15 Bn |